Acquired firm will operate in Intertek’s pharmaceutical services segment.
Intertek has taken over BioClin Research Laboratories. The acquisition advances Intertek’s strategic growth in support services to the global pharmaceutical, medical device, and drug delivery industry.
BioClin will operate in Intertek’s pharmaceutical services group within its analytical services division. Originally based in Ireland, the company has been a supplier of contract bio-analysis and analytical R&D with advanced analytical services including LC/MS/MS for five years. BioClin has a GLP-certified and a cGMP facility.
“BioClin further extends our offering in Europe as well as our global platform supporting pharmaceutical R&D and manufacturing in key locations,” notes John Conti-Ramsden, Ph.D., global director of Intertek’s pharmaceutical services. “Intertek already provides a wide range of testing services to pharmaceutical clients from its laboratories in the United Kingdom, USA, India, and Australia.”
